These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 10662618)

  • 1. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
    Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M
    Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes.
    Gladow M; Becker C; Blankenstein T; Uckert W
    J Gene Med; 2000; 2(6):409-15. PubMed ID: 11199261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
    Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
    Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.
    Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K
    Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange.
    Steidl S; Stitz J; Schmitt I; König R; Flory E; Schweizer M; Cichutek K
    Virology; 2002 Sep; 300(2):205-16. PubMed ID: 12350351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
    Engelstädter M; Buchholz CJ; Bobkova M; Steidl S; Merget-Millitzer H; Willemsen RA; Stitz J; Cichutek K
    Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
    Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses.
    Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H
    Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells.
    Indraccolo S; Minuzzo S; Feroli F; Mammano F; Calderazzo F; Chieco-Bianchi L; Amadori A
    Gene Ther; 1998 Feb; 5(2):209-17. PubMed ID: 9578840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V; Muriaux D; Darlix JL; Cosset FL
    J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MuLV-based vectors pseudotyped with truncated HIV glycoproteins mediate specific gene transfer in CD4+ peripheral blood lymphocytes.
    Lodge R; Subbramanian RA; Forget J; Lemay G; Cohen EA
    Gene Ther; 1998 May; 5(5):655-64. PubMed ID: 9797870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression cloning of new receptors used by simian and human immunodeficiency viruses.
    Deng HK; Unutmaz D; KewalRamani VN; Littman DR
    Nature; 1997 Jul; 388(6639):296-300. PubMed ID: 9230441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.
    Riddick NE; Wu F; Matsuda K; Whitted S; Ourmanov I; Goldstein S; Goeken RM; Plishka RJ; Buckler-White A; Brenchley JM; Hirsch VM
    J Virol; 2015 Dec; 90(5):2316-31. PubMed ID: 26656714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.